Thursday 25 April | |
Acacia Mining | Q1 Results |
RELX | Trading Statement |
Anglo American | Q1 Production |
Devro | Trading Statement |
RDI REIT | Half Year Results |
Tullow Oil | Trading Statement |
Barclays | Q1 Results |
KAZ Minerals | Q1 Results |
Senior | Trading Statement |
Meggitt | Trading Statement |
Taylor Wimpey | Trading Statement |
Synthomer | Trading Statement |
Carpetright | Trading Statement |
Friday 26 April | |
WPP | Q1 Results |
Hastings Group | Q1 Results |
Allied Minds | Full Year Results |
Computacenter | Q1 Results |
Rotork | Trading Statement |
Royal Bank of Scotand Group | Q1 Results |
Just Eat | Q1 Results |
AstraZeneca | Q1 Results |
AJ Bell | Trading Statement |
Georgia Capital | Q1 Results |
Monday 29 April | |
Evraz | Q1 Results |
UP Global Sourcing | Half Year Results |
Horizon Discovery Group | Full Year Results |
River & Merantile | Q3 Results |
Tuesday 30 April | |
BP | Q1 Results |
Standard Chartered | Q1 Results (at 0515 BST) |
Elementis | Trading Statement |
Glencore | Q1 Production |
St James's Place | Q1 Results |
Whitbread | Full Year Results |
Weir Group | Q1 Results |
Breedon Group | Trading Statement |
Jupiter Fund Management | Q1 Results |
Hochschild Mining | Q1 Production |
Greene King | Trading Statement |
C4X Discovery | Half Year Results |
Animalcare | Full Year Results |
Xeros Technology Group | Full Year Results |
Focusrite | Half Year Results |
Wednesday 1 May | |
J Sainsbury | Full Year Results |
Connect Group | Half Year Results |
Indivior | Q1 Results |
AIB Group | Q1 Results |
London Stock Exchange Group | Q1 Results |
Metro Bank | Q1 Results |
IWG | Q1 Results |
Inmarsat | Q1 Results |
Next | Q1 Results |
Persimmon | Trading Statement |
GlaxoSmithKline | Q1 Results (at 1200 BST) |
Rank Group | Trading Statement |
RPS Group | Trading Statement |
Avon Rubber | Half Year Results |
Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs
WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.
Read more